GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: ZN148
Compound class:
Synthetic organic
Comment: APC148 (ZN148) is a zinc-chelating β-lactamase inhibitor [1]. It is in clinical development as an adjuvant to be used with reserve group antibacterials for the treatment of patients with complicated Gram-negative infections.
|
|
|||||||||||||||||||||||||||||||||||
| No information available. |
Summary of Clinical Use ![]() |
| A Phase 1 first-in-human trial to evaluate the safety, tolerability, and pharmacokinetics of APC148 in healthy adults (NCT06360640) has been registered but is not yet recruiting (last update April 2024). |
| Clinical Trials | |||||
| Clinical Trial ID | Title | Type | Source | Comment | References |
| NCT06360640 | A First-in-human Trial to Evaluate Safety, Tolerability, and Pharmacokinetics of APC148 in Healthy Adults | Phase 1 Interventional | AdjuTec Pharma AS | ||